Retrospective Observational Study of Implant-supported Restorations With Dental Implants.
1 other identifier
interventional
100
1 country
1
Brief Summary
This retrospective study aims to value the bone loss and the success and survival of the dental implants produced by additive manufacturing installed in an area grafted with Plenum® Osshp (synthetic bone graft). In addition, the biological and biomechanical performance of implant restorations supported through an observational retrospective solution will be observed. From 50 to 100 survey participants will be selected, who will be invited to attend the clinic for clinical, radiographic, and prosthetic evaluation and successful parameters between baseline, 3, 6, and 12 months. The data obtained regarding bone loss (primary outcome) of the analyzed regions and implant success and survival in area grafted with Plenum® Osshp (secondary outcome) will be evaluated by the paired t-test for the evaluation of the times (3, 6, and 12 months) and survival curves of the installed dental implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 14, 2023
CompletedFirst Posted
Study publicly available on registry
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedMarch 12, 2024
November 1, 2023
5.6 years
November 14, 2023
March 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The survival rate of dental implants produced by additive manufacturing installed in pristine bone and grafted areas with synthetic bone graft (Plenum® Osshp).
The main outcome is the survival rate (%) of successful implant-supported restoration after at least 1-year of occlusal loading (less than 0.5mm of bone loss)
12 months
Secondary Outcomes (2)
The survival rate of dental implants produced by additive manufacturing installed in different areas grafted with synthetic bone grafts (Plenum® Osshp)
12 months
Rate of bone loss
12 months
Study Arms (3)
Dental Implants installed in an grafted area (sinus lifting)
EXPERIMENTALDental implants produced by additive manufacturing installed in an area grafted with synthetic bone graft (Plenum® Osshp) - sinus lifting.
Dental Implants installed in an grafted area (ridge augmentation)
EXPERIMENTALDental implants produced by additive manufacturing installed in an area grafted with synthetic bone graft (Plenum® Osshp) - ridge augmentation.
Dental Implants installed in an grafted area (extraction sites)
EXPERIMENTALDental implants produced by additive manufacturing installed in an area grafted with synthetic bone graft (Plenum® Osshp) - extraction sites (socket preservation or dental implant preparation/placement).
Interventions
The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.
The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.
The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.
Eligibility Criteria
You may qualify if:
- Clinical parameters:
- Presence or absence of pain or tenderness
- Presence or absence of suppuration or exudation
- Presence or absence of mobility
- Prosthetic parameters
- \- Presence or absence of mechanical complications (problems in prefabricated components such as screws and abutments).
- Radiographic Parameters
- Presence or absence of peri-implant radiolucidity.
- maintenance and quality of the bone graft volume in the grafted area to each clinical indication: ridge augmentation, extraction sites (socket preservation or dental implant preparation/placement) and sinus lifting.
- Distance between the shoulder of the implant and the first visible bone contact (in mm).
- Presence or absence of technical complications such as fracture or loss of porcelain structures.
- Success Parameters
- Absence of pain or tenderness.
- Absence of suppuration or exudation.
- Clinical absence of implant mobility.
- +3 more criteria
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M3 Healthlead
- University of Guarulhoscollaborator
Study Sites (1)
University of Guarulhos
Guarulhos, São Paulo, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamil A Shibli, PhD
University of Guarulhos, UnG
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2023
First Posted
December 1, 2023
Study Start
January 1, 2019
Primary Completion
July 30, 2024
Study Completion
July 30, 2024
Last Updated
March 12, 2024
Record last verified: 2023-11